We are grateful to all researchers & scientists worldwide who used our products. It is an honor for us that our products work for you. Following are some of the publications in which Selleck products were used.
MicroRNA-21 orchestrates high glucose-induced signals to TOR complex 1, resulting in renal cell pathology in diabetes.
J Biol Chem 2011 286(29):25586-603MK-2206 2HClpurchased from Selleck Chemicals.
The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma.
Gynecol Oncol 2011 123(1):13-8MK-2206 2HClpurchased from Selleck Chemicals.
CBL mutants activate AKT to induce transformation in cooperation with class III receptor tyrosine kinases.
Exp Hematol 2013 41(3):271-280.e4MK-2206 2HClpurchased from Selleck Chemicals.
Relaxin induces rapid dilation of rodent small renal and human subcutaneous arteries via PI3 kinase and nitric oxide.
Endocrinology 2011 152(7):2786-96MK-2206 2HClpurchased from Selleck Chemicals.
Akt Inhibitors MK-2206 and Nelfinavir Overcome mTOR Inhibitor Resistance in Diffuse Large B-cell Lymphoma.
Clin Cancer Res 2012 18(9):2534-44MK-2206 2HClpurchased from Selleck Chemicals.
Selective Cox-2 inhibitor celecoxib induces epithelial-mesenchymal transition in human lung cancer cells via activating MEK-ERK signaling.
Carcinogenesis 2013 34(3):638-46MK-2206 2HClpurchased from Selleck Chemicals.
